Om

Proacta S.A. is a technology company specializing in advanced data analytics and artificial intelligence solutions for the healthcare and life sciences sectors. Based in Poland, the company focuses on creating predictive and analytical models that support medical decision-making, improve patient care, and optimize operational processes for hospitals, clinics, and pharmaceutical organizations. Proacta S.A. develops bioinformatics tools and AI-driven platforms that help interpret complex medical and biological data, enabling more precise diagnostics, treatment personalization, and resource management. Its offerings include machine learning–based analytics, algorithm development, and tailored software solutions that integrate with existing healthcare IT systems. By combining expertise in medicine, statistics, and computer science, Proacta S.A. plays a role in the growing field of AI-based medicine, supporting both clinical practice and research environments. The company serves a broad range of institutional clients seeking to use modern technologies to enhance quality of care, reduce costs, and increase efficiency in healthcare delivery.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I PROACTA MED ENDAVU: Køb PROACTA ($WS3) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i PROACTA, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.